About the Company
Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates. The company traces its roots to Environmental Sciences Corporation, formed in 1968. It was known as Hazleton from 1972 to 1990, Corning Lab Services from 1990 to 1996, Covance from 1996 to 2021, and Labcorp Drug Development from 2021 to 2023.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Fortrea Holdings Inc.
Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.03 per share a year ago. These ...
Fortrea Holdings Inc. (NASDAQ:FTRE) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 6, 2025 Fortrea Holdings Inc. beats earnings expectations. Reported EPS is $0.19, ...
FTRE NEWS: Fortrea Holdings Inc. Was Sued for Fraud - WFLA
In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ("Labcorp").
FTRE CLASS ACTION ALERT: Fortrea Holdings Inc. Investors with Losses ...
In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ("Labcorp").
FTRE CLASS ACTION NOTICE: Fortrea Holdings Inc. Was Sued For Securities ...
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and ...
FTRE INVESTOR DEADLINE: Fortrea Holdings Inc. Investors with ...
Fortrea Holdings Inc., No. 25-cv-04630 (S.D.N.Y.), the Fortrea class action lawsuit charges Fortrea and certain of Fortrea's top executives with violations of the Securities Exchange Act of 1934.
Fortrea Holdings Inc. Class Action: Levi & Korsinsky Reminds Fortrea ...
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortrea Holdings Inc. investors who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025.
FTRE NEWS: Fortrea Holdings Inc. Was Sued for Fraud - Investors With ...
On this news, the price of Fortrea stock declined $3.47 per share, or over 25%, from a closing price of $13.85 per share on February 28, 2025, to $10.38 per share on March 3, 2025, the next ...
FTRE CLASS ACTION ALERT: Fortrea Holdings Inc. Investors with Losses ...
On this news, the price of Fortrea stock declined $3.47 per share, or over 25%, from a closing price of $13.85 per share on February 28, 2025, to $10.38 per share on March 3, 2025, the next ...
FTRE CLASS ACTION NOTICE: Fortrea Holdings Inc. Was Sued For Securities ...
In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ("Labcorp").
Similar Companies
Loading the latest forecasts...